Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade
Open accessThe DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
The "Amyloid Cascade Hypothesis" has dominated the Alzheimer's disease (AD) field in the last 25 years. It posits that the increase of amyloid-β (Aβ) is the key event in AD that triggers tau pathology followed by neuronal death and eventually, the disease. However, therapeutic approaches aimed at decreasing Aβ levels have so far failed, and tau-based clinical trials have not yet produced positive findings. This begs the question of whether the hypothesis is correct. Here we have examined literature on the role of Aβ and tau in synaptic dysfunction, memory loss, and seeding and spreading of AD, highlighting important parallelisms between the two proteins in all of these phenomena. We discuss novel findings showing binding of both Aβ and tau oligomers to amyloid-β protein precursor (AβPP), and the requirement for the presence of this protein for both Aβ and tau to enter neurons and induce abnormal synaptic function and memory. Most importantly, we propose a novel view of AD pathogenesis in which extracellular oligomers of Aβ and tau act in parallel and upstream of AβPP. Such a view will call for a reconsideration of therapeutic approaches directed against Aβ and tau, paving the way to an increased interest toward AβPP, both for understanding the pathogenesis of the disease and elaborating new therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TRx0237 (21, LMTX) is a tau aggregation inhibitor.465”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [465]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Also, tau pathology is likely to begin in EC then move to the hippocampus, and ultimately invading the cortex, following an overlapping path existing among functionally connected areas [55, 157, 158, 177].”
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 3×
“Unfortunately, while the “Oligomer Hypothesis” is still a matter of investigation, and data are being gathered to test the grounds of its premises, the clinical failure of most of the anti-A (cid:2) drugs has strongly destabilized this concept.”
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Second, we know since the 1990 s that there is no correlation between A (cid:2) deposition and clinical degree of dementia among affected individuals [25–28], and plaques might occur in the brains of individuals with no sign of dementia [27, 29, 30].”
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“This was predicted by a study showing that all of the soluble oligomers tested including β-synuclein, islet amyloid polypeptide, polyglutamine, lysozyme, human insulin, and prion peptide 106–126, display a common conformation-dependent structure that is unique to soluble oligomers [193], By now, a variety of studies h…”
BackgroundClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · cited 1×
“This temporal sequence derives from studies in patients with FAD, where the genetic-driven increase of Aβ is followed by NFT accumulation [194], whereas the increase of tau, as in tauopathies, is not associated with Aβ deposition.”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089 · cited 1×
“Tau is a microtubule-associated protein originally described as a heat stable protein essential for microtubule assembly and stabilization [42].”
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“These findings contributed to the excitement around the “Amyloid Cascade Hypothesis” [13–15], recognized as the pathogenic mechanism underlying AD.”
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“Based on these data, in 1995 the first mouse model of AD carrying an AβPP mutation was engineered [11] and, over time, different models for pre-clinical studies have been generated based on the most common mutations observed in FAD [12].”
MethodTau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251 · cited 4×
“Interestingly, when in a solution, tau spontaneously tends to modify its conformation in favor of a paperclip like structure that might prevent its aggregation [55, 82], unlike Aβ that has a high tendency to aggregate in a solution due to its biochemical properties.”
BackgroundInfluential(2015) · HAL · Cited by 2,238
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · cited 2×
“Moreover, in the P301S model of tauopathy, synaptic damage and cognitive impairment occurred before the emergence of NFTs [94].”
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 4×
“This phenomenon is defined as seeding [161, 183] and can be distinguished as homologous or heterologous [183, 187].”
InfluentialFunction and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127
Nanotubular Highways for Intercellular Organelle Transport
Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H.-H. (2004) · Science · doi:10.1126/science.1093133 · Cited by 2,038 · cited 1×
“Another mechanism proposed for Aβ spreading relies on the presence of tunneling nanotubes (TNTs) consisting of cellular membrane extensions creating a direct connection between cells [172].”
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · cited 2×
“Other studies on transgenic mice expressing mutant tau (P301L mutation), which could be suppressed with doxycycline, demonstrated that behavioral impairment and neuronal loss were recovered when suppressing transgenic tau, whereas NFTs accumulation continued [93].”
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“, picrotoxin) neuronal activity have shown a concomitant decrease or increase of Aβ secretion in organotypic slices overexpressing human AβPP Swedish mutation [136].”
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“Consistent with this finding, tau has been found in exosomes that might lead to its diffusion to adjacent cells [106, 179].”
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506 · cited 1×
“While spreading is involved in the progression of the disease among functionally connected brain areas, the transition from oligomers to insoluble deposits has been described as a “nucleation-dependent protein polymerization” and explains the pattern of aggregate formation [183] for proteins with high tendency to orga…”
BackgroundSilva, A. J., Kogan, J. H., Frankland, P. W., & Kida, S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.127 · Cited by 1,462 · cited 1×
“BothA (cid:2) and tau interfere with the transcription factor cAMP response element-binding protein (CREB), whose phosphorylation at Ser133 is thought to be one of the fundamental events in memory formation [110–112].”
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
CARLEZONJR, W., DUMAN, R., & NESTLER, E. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,346 · cited 1×
“BothA (cid:2) and tau interfere with the transcription factor cAMP response element-binding protein (CREB), whose phosphorylation at Ser133 is thought to be one of the fundamental events in memory formation [110–112].”
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343 · cited 1×
“However, Aβ has been shown to be secreted by neurons through exosomes [174] that could be internalized and stored from the acceptor neuron as lysosomal vesicles through a macroautophagy mediated mechanism [170, 175].”
BackgroundSynaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265 · cited 1×
“An in vivo approach by using microdialysis also revealed an increase of Aβ levels in the brain interstitial fluid concomitant to the increase of synaptic activity [137] or paralleling the neurological status [138].”
BackgroundPropagation of Tau Misfolding from the Outside to the Inside of a Cell
Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252 · cited 1×
“On the other hand, several pre-clinical studies have demonstrated that exogenously applied tau can be internalized by neurons [98, 149–152] and glial cells [153–155] with different mechanisms involving bulk endocytosis [152], binding to heparan sulfate proteoglycans [156] or to A (cid:2) PP [144].”
Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225 · cited 1×
“Second, we know since the 1990 s that there is no correlation between Aβ deposition and clinical degree of dementia among affected individuals [25–28], and plaques might occur in the brains of individuals with no sign of dementia [27, 29, 30].”
BackgroundVerret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216 · cited 1×
“Ourfindingsarealsocon-sistentwiththeobservationthatA (cid:2) PP is involved in AD hippocampal hyperactivity [140, 201–204].”
A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60
Cao, X., & Südhof, T. C. (2001) · Science · doi:10.1126/science.1058783 · Cited by 1,202 · cited 1×
“Interest-ingly, it is known that AID/AICD might stimulate transcription by forming a multimeric complex with the nuclear adaptor protein Fe65 and the histone acetyltransferase Tip60 [214].”
The worldwide costs of dementia 2015 and comparisons with 2010
Wimo, A., Guerchet, M., Ali, G., Wu, Y., Prina, A. M., Winblad, B., Jönsson, L., Liu, Z., & Prince, M. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.07.150 · Cited by 1,066 · cited 1×
“Besidesrepresentingaserioushealthand socialproblem,thediseasecausesexorbitantcostsfor the healthcare system estimated as 604 billion dollars in 2010 that represented a 35.4% increase in only 5 years [1, 2].”
InfluentialPrinciples of protein–protein recognition
Chothia, C., & Janin, J. (1975) · Nature · doi:10.1038/256705a0 · Cited by 1,039 · cited 1×
“In the nucleation phase, the nucleus formation requires the assembly of misfolded monomers, a thermodynamically unfavorable process remarkably dependent on protein concentration [161, 185, 186].”
BackgroundSoluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038 · cited 1×
“Althoughcorticalatrophyandsynap-ticlosshavebeenreportedinADbrains,mainlydue toastructuraldamageimputabletoplaquesandtan-glesinalaterstageofthedisease,asubtleeffect exertedbysolubleformsofA (cid:2) and tau at the synapse seems to be the earlier event underlying memory loss [98, 99, 107, 108].”
von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5129 · Cited by 1,021
Trans-Synaptic Spread of Tau Pathology In Vivo
Liu, L., Drouet, V., Wu, J. W., Witter, M. P., Small, S. A., Clelland, C., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 1,002 · cited 3×
“Accordingly, in a transgenic mouse model differentially expressing pathological human tau in EC (EC-tau), the localization of tauopathy was investigated at different time points, demonstrating a progression of the pathology through anatomically and functionally connected brain areas [158].”
Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., & Powell, T. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4531 · Cited by 987 · cited 1×
“Evidence for AD spreading and progression throughout the cortex was reported more than 30 years ago, based on tangle distribution in the proximity of the same pyramidal neurons that give connectivity to other brain areas [160].”
BackgroundDistinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies
Sanders, D. W., Kaufman, S. K., DeVos, S. L., Sharma, A. M., Mirbaha, H., Li, A., Barker, S. J., Foley, A. C., Thorpe, J. R., Serpell, L. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.047 · Cited by 986 · cited 1×
“On the other hand, a growing body of evidence refers to tau spreading as a prion-like propagation, which fascinatingly occurs in different directions among the many forms of tauopathies [176].”
BackgroundSaman, S., Kim, W., Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, A. C., Alvarez, V. E., Lee, N. C. Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277061 · Cited by 985 · cited 3×
“Consistent with this finding, tau has been found in exosomes that might lead to its diffusion to adjacent cells [106, 179].”
APP processing in Alzheimer’s disease.
Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983 · cited 1×
“Based on this biochemical processing, the cascade initiated by α-secretase has been considered neuroprotective when compared with the β-secretase cleavage, leading to the amyloidogenic cascade and the formation of Aβ [5].”
Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
Bakker, A., Krauss, G. L., Albert, M. S., Speck, C. L., Jones, L. R., Stark, C. E., Yassa, M. A., Bassett, S. S., Shelton, A. L., & Gallagher, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.023 · Cited by 908
Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., & Glabe, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400260200 · Cited by 902 · cited 1×
“Whether AβPP acts as a channel permeable to the oligomers [210, 211], or induces the formation of pores across the membrane to let oligomers enter the cell [212], or promotes endocytosis of the oligomers [213], is still under investigation.”
BackgroundMeunier, M., Bachevalier, J., Mishkin, M., & Murray, E. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05418.1993 · Cited by 901 · cited 1×
“These evidences are consistent with data coming from studies on non-human primates in which bilateral lesions of EC induce a functional impairment of declarative memory accompanied by long-lasting hypometabolism in temporal and parietal lobes, demonstrating a functional connection starting from EC [178].”
Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899 · cited 4×
“From a functional point of view, tau can be divided in four different regions consisting of a N-terminal domain, a proline-rich domain, a MBD, and a C-terminal domain [3, 55, 56].”
InfluentialJin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M. O., Brodsky, F. M., Marasa, J., Bagchi, D. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301440110 · Cited by 859 · cited 1×
“On the other hand, several pre-clinical studies have demonstrated that exogenously applied tau can be internalized by neurons [98, 149–152] and glial cells [153– 155] with different mechanisms involving bulk endocytosis [152], binding to heparan sulfate proteoglycans [156] or to AβPP [144].”
BackgroundAlonso, A. D. C., Zaidi, T., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 827
Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820 · cited 1×
“The flanking region of MBD contains the majority of phosphate acceptor residues, and the phosphorylation of these sites is relevant for regulating microtubule polymerization [63–66], regulation of axonal transport [67] and neurotransmitter receptors [68, 69], interference with vesicles trafficking [70] and apolipoprot…”
Neuronal activity enhances tau propagation and tau pathology in vivo
Wu, J. W., Hussaini, S. A., Bastille, I. M., Rodriguez, G. A., Mrejeru, A., Rilett, K., Sanders, D. W., Cook, C., Fu, H., Boonen, R. A. C. M., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4328 · Cited by 820 · cited 2×
“Further work demonstrated that cell-to-cell contact was not necessarily needed for tau spreading in vitro given that the administration of neuronal-derived tau media to neuronal cultures was sufficient for tau transfer and internalization, even though it is not known whether tau in the media was vesicle bound or free…”
Köpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779
The case for rejecting the amyloid cascade hypothesis
Herrup, K. (2015) · Nature Neuroscience · doi:10.1038/nn.4017 · Cited by 768 · cited 1×
“In conclusion, taking into account almost one century of research, it emerges that the Aβ model of AD is insufficient [40, 41] and needs to be reconsidered [34].”
BackgroundSeizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Vossel, K. A., Beagle, A. J., Rabinovici, G. D., Shu, H., Lee, S. E., Naasan, G., Hegde, M., Cornes, S. B., Henry, M. L., Nelson, A. B., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.136 · Cited by 741 · cited 1×
“However, although an increase of brain activity in AD could be supported by data indicating hyperexcitability in transgenic mice and human AD patients [139, 140], this activity-dependent role of Aβ should be better viewed as a physiological mechanism occurring within the healthy brain, especially because levels of Aβ…”
BackgroundPicomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · cited 1×
“However, although an increase of brain activity in AD could be supported by data indicating hyperexcitability in transgenic mice and human AD patients [139, 140], this activity-dependent role of Aβ should be better viewed as a physiological mechanism occurring within the healthy brain, especially because levels of Aβ…”
Self-citationBusche, M. A., Chen, X., Henning, H. A., Reichwald, J., Staufenbiel, M., Sakmann, B., & Konnerth, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206171109 · Cited by 715
Structural Polymorphism of 441-Residue Tau at Single Residue Resolution
Mukrasch, M. D., Bibow, S., Korukottu, J., Jeganathan, S., Biernat, J., Griesinger, C., Mandelkow, E., & Zweckstetter, M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000034 · Cited by 652 · cited 1×
“Although tau has been defined as a “natively unfolded” protein with a low tendency to aggregation [79], phosphorylation of certain residues or detachment from microtubules [79–81] might change its conformational status and consequently its aggregation propensity.”
BackgroundPhysiological release of endogenous tau is stimulated by neuronal activity
Pooler, A. M., Phillips, E. C., Lau, D. H. W., Noble, W., & Hanger, D. P. (2013) · The EMBO Reports · doi:10.1038/embor.2013.15 · Cited by 642 · cited 1×
“Indeed, application of KCl or glutamate to cultured neurons resulted in an increase of tau secretion [98, 146] mediated by AMPA receptor activation [146].”
BackgroundSeeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles
Guo, J. L., & Lee, V. M.-Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209296 · Cited by 636
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Clos, A. L., Jackson, G. R., & Kayed, R. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-39 · Cited by 633 · cited 2×
“Although cortical atrophy and synaptic loss have been reported in AD brains, mainly due to a structural damage imputable to plaques and tangles in a later stage of the disease, a subtle effect exerted by soluble forms of Aβ and tau at the synapse seems to be the earlier event underlying memory loss [98, 99, 107, 108].”
BackgroundResultBrandt, R., Léger, J., & Lee, G. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.5.1327 · Cited by 625 · cited 1×
“…sites is relevant for regulating microtubule polymerization [63–66], regulation of axonal transport [67] and neurotransmitter receptors [68, 69], interference with vesicles traffick-ing [70] and apolipoprotein E [71], interaction with Src-family kinases [62, 72–75], and many others [3, 55, 56].”
Prions hijack tunnelling nanotubes for intercellular spread
Gousset, K., Schiff, E., Langevin, C., Marijanovic, Z., Caputo, A., Browman, D. T., Chenouard, N., de Chaumont, F., Martino, A., Enninga, J., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1841 · Cited by 615 · cited 1×
“Other studies suggested that pathologic tau requires TNTs to be transferred from a neuron to another one [180].”
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609 · cited 2×
“From a functional point of view, tau can be divided in four different regions consisting of a N-terminal domain, a proline-rich domain, a MBD, and a C-terminal domain [3, 55, 56].”
Neuronal activity regulates extracellular tau in vivo
Yamada, K., Holth, J. K., Liao, F., Stewart, F. R., Mahan, T. E., Jiang, H., Cirrito, J. R., Patel, T. K., Hochgräfe, K., Mandelkow, E.-M., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131685 · Cited by 581 · cited 2×
“An increase of tau secretion also paralleled the increase of glutamate release induced by an antagonist of metabotropic glutamate receptors 2/3 [147].”
Schneider, A., Biernat, J., von Bergen, M., Mandelkow, E., & Mandelkow, E.-M. (1999) · Biochemistry · doi:10.1021/bi981874p · Cited by 564 · cited 1×
“First, tau phosphorylation has been demonstrated to be responsible for aggregation only when occurring at certain residues[86],whereasinothersitesithastheopposite effectthuspreventingaggregation[80].”
Tau protein binds to microtubules through a flexible array of distributed weak sites.
Butner, K. A., & Kirschner, M. W. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.3.717 · Cited by 550
Wu, J. W., Herman, M., Liu, L., Simoes, S., Acker, C. M., Figueroa, H., Steinberg, J. I., Margittai, M., Kayed, R., Zurzolo, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394528 · Cited by 537 · cited 2×
“On the other hand, several pre-clinical studies have demonstrated that exogenously applied tau can be internalized by neurons [98, 149–152] and glial cells [153– 155] with different mechanisms involving bulk endocytosis [152], binding to heparan sulfate proteoglycans [156] or to AβPP [144].”
BackgroundVitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., & Shelanski, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172504199 · Cited by 534
Self-citationInhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice
Dawson, H. N., Ferreira, A., Eyster, M. V., Ghoshal, N., Binder, L. I., & Vitek, M. P. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.6.1179 · Cited by 527
Hofrichter, J., Ross, P. D., & Eaton, W. A. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.12.4864 · Cited by 519 · cited 1×
“In the nucleation phase, the nucleus formation requires the assembly of misfolded monomers, a thermodynamically unfavorable process remarkably dependent on protein concentration [161, 185, 186].”
The microtubule binding domain of tau protein
Lee, G., Neve, R. L., & Kosik, K. S. (1989) · Neuron · doi:10.1016/0896-6273(89)90050-0 · Cited by 500
Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., Wszolek, Z., Ashe, K., Knight, J., Dickson, D., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0587-07.2007 · Cited by 485 · cited 1×
“These results are in agreement with other observations reporting that tau oligomers 1) impair synaptic function and memory in wild type mice [99], 2) correlate with cognitive impairment in rTg4510 mice [100], and 3) accelerate pathology in hTau mice [101].”
Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., & Roses, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11183 · Cited by 474 · cited 1×
“…sites is relevant for regulating microtubule polymerization [63–66], regulation of axonal transport [67] and neurotransmitter receptors [68, 69], interference with vesicles traffick-ing [70] and apolipoprotein E [71], interaction with Src-family kinases [62, 72–75], and many others [3, 55, 56].”
Multiple-motor based transport and its regulation by Tau
Vershinin, M., Carter, B. C., Razafsky, D. S., King, S. J., & Gross, S. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607919104 · Cited by 457
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · cited 3×
“Unfortunately, while the “Oligomer Hypothesis” is still a matter of investigation, and data are being gathered to test the grounds of its premises, the clinical failure of most of the anti-A (cid:2) drugs has strongly destabilized this concept.”
Global Hairpin Folding of Tau in Solution
Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H.-J., & Mandelkow, E. (2006) · Biochemistry · doi:10.1021/bi0521543 · Cited by 432 · cited 2×
“However, the undefined structure of tau in solution has precluded crystallographic analyses leaving a lack of knowledge about the protein structure [82].”
Interactions of pathological proteins in neurodegenerative diseases
Spires-Jones, T. L., Attems, J., & Thal, D. R. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1709-7 · Cited by 429 · cited 2×
“-synuclein and TDP-43 [188].”
Nuclear Tau, a Key Player in Neuronal DNA Protection
Sultan, A., Nesslany, F., Violet, M., Bégard, S., Loyens, A., Talahari, S., Mansuroglu, Z., Marzin, D., Sergeant, N., Humez, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199976 · Cited by 421
Tunneling-nanotube development in astrocytes depends on p53 activation
Wang, Y., Cui, J., Sun, X., & Zhang, Y. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.147 · Cited by 417 · cited 1×
“TNTs have been demonstrated to mediate high-speed transfer of Aβ among neurons, through a p53/EGFR/Akt/PI3K/mTOR pathway that, in turn, would trigger F-actin polymerization promoting TNTs formation [173].”
BackgroundCorrelations of synaptic and pathological markers with cognition of the elderly
Dickson, D. W., Crystal, H. A., Bevona, C., Honer, W., Vincent, I., & Davies, P. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00013-5 · Cited by 410 · cited 1×
“Second, we know since the 1990 s that there is no correlation between A (cid:2) deposition and clinical degree of dementia among affected individuals [25–28], and plaques might occur in the brains of individuals with no sign of dementia [27, 29, 30].”
Cheng, I. H., Scearce-Levie, K., Legleiter, J., Palop, J. J., Gerstein, H., Bien-Ly, N., Puolivaöli, J., Lesné, S., Ashe, K. H., Muchowski, P. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701078200 · Cited by 407
Palop, J. J., Jones, B., Kekonius, L., Chin, J., Yu, G.-Q., Raber, J., Masliah, E., & Mucke, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133381100 · Cited by 402 · cited 1×
“EC superficial layer is susceptible to A (cid:2) -dependent neurodegeneration, and this can negatively affect its primary afferent regions resulting in a disruption of the whole circuitry in both mouse models and AD patients [163, 164].”
Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)
Dickson, D. W., Kouri, N., Murray, M. E., & Josephs, K. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9589-0 · Cited by 380 · cited 5×
“The proline-rich domain and the MBD with their multiple aminoacidic acceptor residues are more involved in interactions with different signaling proteins, which can be scaf-folded by tau or can modify tau conformational status and activity itself [3].”
InfluentialAlzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
Reitz, C. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/369808 · Cited by 376 · cited 1×
“Third, recent studies have suggested that plaque formation might be a reactive process [31] with a protective role by decreasing oligomer levels [32].”
BackgroundAlzheimer’s pathogenesis: is there neuron-to-neuron propagation?
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0825-z · Cited by 359 · cited 2×
“Also, tau pathology is likely to begin in EC then move to the hippocampus, and ultimately invading the cortex, following an overlapping path existing among functionally connected areas [55, 157, 158, 177].”
Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease
Patterson, K. R., Remmers, C., Fu, Y., Brooker, S., Kanaan, N. M., Vana, L., Ward, S., Reyes, J. F., Philibert, K., Glucksman, M. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237974 · Cited by 357 · cited 1×
“, monomers, dimers, oligomers, pre-tangles, and tangles [104].”
Repeat motifs of tau bind to the insides of microtubules in the absence of taxol
Kar, S., Fan, J., Smith, M. J., Goedert, M., & Amos, L. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg001 · Cited by 355 · cited 2×
“Both R and N repeats are capable of microtubule-binding and assembly-promoting activity, whereas the flanking regions are more likely involved in binding processes [45, 46].”
Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau
Hardy, J., Duff, K., Hardy, K. G., Perez-Tur, J., & Hutton, M. (1998) · Nature Neuroscience · doi:10.1038/1565 · Cited by 347
Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.
Trinczek, B., Biernat, J., Baumann, K., Mandelkow, E. M., & Mandelkow, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.12.1887 · Cited by 340 · cited 1×
“Both R and N repeats are capable of microtubule-binding and assembly-promoting activity, whereas the flanking regions are more likely involved in binding processes [45,46].”
BackgroundMAP2 and tau bind longitudinally along the outer ridges of microtubule protofilaments
Al-Bassam, J., Ozer, R. S., Safer, D., Halpain, S., & Milligan, R. A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201048 · Cited by 327 · cited 1×
“Moreover, notwithstanding electron microscopic visualization of tau bound to micro-tubules demonstrated a linear alignment lengthwise totheprotofilamentridges,theproteinstructurekeeps holdingadisorderedstate[83,84].”
Sites of Tau Important for Aggregation Populate β-Structure and Bind to Microtubules and Polyanions
Mukrasch, M. D., Biernat, J., von Bergen, M., Griesinger, C., Mandelkow, E., & Zweckstetter, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501565200 · Cited by 324
Harris, J. A., Devidze, N., Verret, L., Ho, K., Halabisky, B., Thwin, M. T., Kim, D., Hamto, P., Lo, I., Yu, G.-Q., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.020 · Cited by 319
Physiological Functions of APP Family Proteins
Muller, U. C., & Zheng, H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006288 · Cited by 310 · cited 2×
“A strategy directed against AβPP will likely have its own drawbacks including physiological functions of full length AβPP [4].”
Suspected non-Alzheimer disease pathophysiology — concept and controversy
Jack, C. R., Knopman, D. S., Chételat, G., Dickson, D., Fagan, A. M., Frisoni, G. B., Jagust, W., Mormino, E. C., Petersen, R. C., Sperling, R. A., et al. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.251 · Cited by 306
Steiner, B., Mandelkow, E. M., Biernat, J., Gustke, N., Meyer, H. E., Schmidt, B., Mieskes, G., Söling, H. D., Drechsel, D., & Kirschner, M. W. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07563.x · Cited by 304 · cited 1×
“CaMKII phosphorylates [130]andmodifytaustructureleading toPHFsformation[131].”
Functional MRI of the vocalization-processing network in the macaque brain
Ortiz-Rios, M., KuÅ›mierek, P., DeWitt, I., Archakov, D., Azevedo, F. A. C., Sams, M., Jääskeläinen, I. P., Keliris, G. A., & Rauschecker, J. P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00113 · Cited by 304
Increased levels of granular tau oligomers: An early sign of brain aging and Alzheimer's disease
Maeda, S., Sahara, N., Saito, Y., Murayama, S., Ikai, A., & Takashima, A. (2006) · Neuroscience Research · doi:10.1016/j.neures.2005.11.009 · Cited by 301 · cited 2×
“Most importantly, increases in granular tau oligomer levels occur before NFTs form and before individuals manifest clinical symptoms of AD, suggesting that increases in tau oligomer levels may represent a very early sign of brain aging and AD [97].”
Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain
Brody, D. L., Magnoni, S., Schwetye, K. E., Spinner, M. L., Esparza, T. J., Stocchetti, N., Zipfel, G. J., & Holtzman, D. M. (2008) · Science · doi:10.1126/science.1161591 · Cited by 295
Goode, B. L., Denis, P. E., Panda, D., Radeke, M. J., Miller, H. P., Wilson, L., & Feinstein, S. C. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.2.353 · Cited by 294
Seizures in Alzheimer Disease: Who, When, and How Common?
Scarmeas, N., Honig, L. S., Choi, H., Cantero, J., Brandt, J., Blacker, D., Albert, M., Amatniek, J. C., Marder, K., Bell, K., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.130 · Cited by 294
Self-citationBolmont, T., Clavaguera, F., Meyer-Luehmann, M., Herzig, M. C., Radde, R., Staufenbiel, M., Lewis, J., Hutton, M., Tolnay, M., & Jucker, M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070403 · Cited by 281 · cited 1×
“Some studies in which spreading of tau pathology was significantly accelerated by injecting pre-aggregated Aβ into mouse brain [189, 190] suggested the possibility of Aβ and tau cross-seeding.”
Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory
Puzzo, D., Privitera, L., Fa', M., Staniszewski, A., Hashimoto, G., Aziz, F., Sakurai, M., Ribe, E. M., Troy, C. M., Mercken, M., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22313 · Cited by 278 · cited 3×
“However, although an increase of brain activity in AD could be supported by data indicating hyperexcitability in transgenic mice and human AD patients [139, 140], this activity-dependent role of Aβ should be better viewed as a physiological mechanism occurring within the healthy brain, especially because levels of Aβ…”
BackgroundSelf-citationMicroglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
Joshi, P., Turola, E., Ruiz, A., Bergami, A., Libera, D. D., Benussi, L., Giussani, P., Magnani, G., Comi, G., Legname, G., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.180 · Cited by 275
Frandemiche, M. L., De Seranno, S., Rush, T., Borel, E., Elie, A., Arnal, I., Lanté, F., & Buisson, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4261-13.2014 · Cited by 272 · cited 1×
“…at different subcellular localizations: 1) at axonal level, by regulating axonal elongation, maturation and transport [47–50]; 2) in dendrites, participating in synaptic plasticity [51, 52]; and 3) in nucleus, maintaining the integrity of genomic DNA, cytoplasmic and nuclear RNA [53, 54].”
Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory
Fá, M., Puzzo, D., Piacentini, R., Staniszewski, A., Zhang, H., Baltrons, M. A., Li Puma, D. D., Chatterjee, I., Li, J., Saeed, F., et al. (2016) · Scientific Reports · doi:10.1038/srep19393 · Cited by 272 · cited 5×
“Although cortical atrophy and synaptic loss have been reported in AD brains, mainly due to a structural damage imputable to plaques and tangles in a later stage of the disease, a subtle effect exerted by soluble forms of Aβ and tau at the synapse seems to be the earlier event underlying memory loss [98, 99, 107, 108].”
InfluentialSelf-citationSöllvander, S., Nikitidou, E., Brolin, R., Söderberg, L., Sehlin, D., Lannfelt, L., & Erlandsson, A. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0098-z · Cited by 267
Jiao, S.-S., Shen, L.-L., Zhu, C., Bu, X.-L., Liu, Y.-H., Liu, C.-H., Yao, X.-Q., Zhang, L.-L., Zhou, H.-D., Walker, D. G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.186 · Cited by 266 · cited 1×
“Recently, a loss of BDNF has been also reported in THY-Tau22 and P301L mouse models of tau pathology [134, 135].”
BackgroundHigh‐molecular‐weight β‐amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D., & Nakagawa, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-150359 · Cited by 264
Baudier, J., & Cole, R. D. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45420-8 · Cited by 262 · cited 1×
“On the other hand, evidences for the interaction tau-CaMKII have been reported since the late 1980 s in works analyzing the ability of CaMKII to induce an AD-like tau phosphorylation [128, 129].”
BackgroundGuo, J.-P., Arai, T., Miklossy, J., & McGeer, P. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509386103 · Cited by 261 · cited 2×
“Moreover, confocal immunohistochemical imaging of AD brains showed intracellular aggregates in which A (cid:2) and tau coex-isted in the same structure [191].”
Planel, E., Miyasaka, T., Launey, T., Chui, D.-H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y., & Takashima, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5561-03.2004 · Cited by 261 · cited 1×
“Moreover, tauhyperphosphorylationisnotaprerogativeofAD, sinceitoccursinseveralotherconditionssuchas hypothermia[87],starvation[88],chronicstress[89], andanesthesia[90,91].”
Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258 · cited 1×
“…at the synapse [144], in agreement with previous observations indicating that A (cid:2) PP mediates extracellular A (cid:2) neurotoxicity [143, 198, 199], and a recent study showing that A (cid:2) PP is required for binding of human brain-derivedoligomerstosynapsesanddisruptionof…”
Sotiropoulos, I., Catania, C., Pinto, L. G., Silva, R., Pollerberg, G. E., Takashima, A., Sousa, N., & Almeida, O. F. X. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0730-11.2011 · Cited by 257 · cited 1×
“Moreover, tauhyperphosphorylationisnotaprerogativeofAD, sinceitoccursinseveralotherconditionssuchas hypothermia[87],starvation[88],chronicstress[89], andanesthesia[90,91].”
Violet, M., Delattre, L., Tardivel, M., Sultan, A., Chauderlier, A., Caillierez, R., Talahari, S., Nesslany, F., Lefebvre, B., Bonnefoy, E., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00084 · Cited by 251 · cited 3×
“In the last decades, many studies have demonstrated tau physiological involvement at different subcellular localizations: 1) at axonal level, by regulating axonal elongation, maturation and transport [47–50]; 2) in dendrites, participating in synaptic plasticity [51, 52]; and 3) in nucleus, maintaining the integrity o…”
Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of -Amyloid
Nath, S., Agholme, L., Kurudenkandy, F. R., Granseth, B., Marcusson, J., & Hallbeck, M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0615-12.2012 · Cited by 244
Specification of synaptic connectivity by cell surface interactions
de Wit, J., & Ghosh, A. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.3 · Cited by 242
Luo, W., Liu, W., Hu, X., Hanna, M., Caravaca, A., & Paul, S. M. (2015) · Scientific Reports · doi:10.1038/srep11161 · Cited by 241
Puzzo, D., Vitolo, O., Trinchese, F., Jacob, J. P., Palmeri, A., & Arancio, O. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5291-04.2005 · Cited by 240
Self-citationBrain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy
Song, J.-H., Yu, J.-T., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8958-4 · Cited by 237 · cited 2×
“Moreover, several in vitro and in vivo studies have confirmed that Aβ-induced LTP and cognitive dysfunction are associated with a reduction of BDNF levels [133].”
BackgroundDownregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons
Pugazhenthi, S., Wang, M., Pham, S., Sze, C.-I., & Eckman, C. B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-60 · Cited by 237 · cited 1×
“Interestingly, these findings were validated in humans affected by AD showing a decrease in CREB and phospho-CREB levels in hippocampus [118–122].”
Brandt, R., & Lee, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53710-8 · Cited by 229 · cited 1×
“Interestingly, the C-terminal domain, besides its key role in regulation of microtubule polymerization induction and interaction with plasma membranes [59–62], creates an overall asymmetry in the molecule contributing to this microtubule spacing function thanks to its neutral charge.”
The Formation of Straight and Twisted Filaments from Short Tau Peptides
Goux, W. J., Kopplin, L., Nguyen, A. D., Leak, K., Rutkofsky, M., Shanmuganandam, V. D., Sharma, D., Inouye, H., & Kirschner, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402379200 · Cited by 227 · cited 1×
“Moreover, notwithstanding electron microscopic visualization of tau bound to microtubules demonstrated a linear alignment lengthwise to the protofilament ridges, the protein structure keeps holding a disordered state [83, 84].”
BackgroundReynolds, C. H., Garwood, C. J., Wray, S., Price, C., Kellie, S., Perera, T., Zvelebil, M., Yang, A., Sheppard, P. W., Varndell, I. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709715200 · Cited by 226
Maas, T., Eidenmüller, J., & Brandt, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000389200 · Cited by 226
Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau
Bhaskar, K., Yen, S.-H., & Lee, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505895200 · Cited by 223
Rodent models for Alzheimer’s disease drug discovery
Puzzo, D., Gulisano, W., Palmeri, A., & Arancio, O. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1041913 · Cited by 222 · cited 6×
“Other genetic mutations were identified in Familiar Alzheimer’s disease (FAD), involving genes responsible for A (cid:2) production such as presenilin 1 (PS1) on chromosome 14, which mutation is the most common cause of EOAD, and presenilin 2 (PS2) on chromosome 1.”
InfluentialSelf-citationEctosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein
Dujardin, S., Bégard, S., Caillierez, R., Lachaud, C., Delattre, L., Carrier, S., Loyens, A., Galas, M.-C., Bousset, L., Melki, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100760 · Cited by 219 · cited 1×
“However, whether the mechanism underlying tau propagation is mediated by TNTs, non-vesicular direct translocation or through secretory lysosomes into extracellular space [106, 162, 181, 182] is still under investigation.”
Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments
Kanemaru, K., Takio, K., Miura, R., Titani, K., & Ihara, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10039.x · Cited by 219
Morales, R., Moreno-Gonzalez, I., & Soto, C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003537 · Cited by 218 · cited 2×
“While spreading is involved in the progression of the disease among functionally connected brain areas, the transition from oligomers to insoluble deposits has been described as a “nucleation-dependent protein polymerization” and explains the pattern of aggregate formation [183] for proteins with high tendency to orga…”
Alzheimer’s disease as an inflammatory disease
Bolós, M., Perea, J. R., & Avila, J. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2016-0029 · Cited by 216
Tau Phosphorylation and Sevoflurane Anesthesia: An Association to Postoperative Cognitive Impairment
Le Freche, H., Brouillette, J., Fernandez-Gomez, F.-J., Patin, P., Caillierez, R., Zommer, N., Sergeant, N., Buée-Scherrer, V., Lebuffe, G., Blum, D., et al. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31824be8c7 · Cited by 212
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
Meredith Jr., J. E., Sankaranarayanan, S., Guss, V., Lanzetti, A. J., Berisha, F., Neely, R. J., Slemmon, J. R., Portelius, E., Zetterberg, H., Blennow, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076523 · Cited by 209 · cited 1×
“We characterized tau immunoreactivity by western blot in CSF samples [105] from a cohort of 11 patients with probable AD and 11 healthy con-trol (HC) individuals at the time of harvesting CSF (Table 1).”
Imaging the progression of Alzheimer pathology through the brain
Smith, A. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082107399 · Cited by 206 · cited 2×
“…studies exploiting computerized x-ray tomography (CT) and magnetic resonance imaging (MRI) techniques, that allow tracing different neuropathological markers such as atrophy of certain brain areas, brain ventricles enlargement, and deposition of amyloid plaques and NFTs (for a review, see [78]).”
Calcium/calmodulin-dependent kinase II and Alzheimer’s disease
Ghosh, A., & Giese, K. P. (2015) · Molecular Brain · doi:10.1186/s13041-015-0166-2 · Cited by 205 · cited 2×
“CaMKII is dysregulated in the hippocampus of AD mouse models and patients (for a review, see [124]) and it has been demonstrated that Aβ oligomers interfere with its phosphorylation leading to AMPA receptor dysfunction [125– 127].”
Yamamoto-Sasaki, M., Ozawa, H., Saito, T., Rösler, M., & Riederer, P. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01220-2 · Cited by 198
The fuzzy coat of pathological human Tau fibrils is a two-layered polyelectrolyte brush
Wegmann, S., Medalsy, I. D., Mandelkow, E., & Müller, D. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212100110 · Cited by 196 · cited 1×
“paperclip-like structure leading to paired helical filament (PHF) and NFT formation [85].”
BackgroundMolecular mechanisms of CaMKII activation in neuronal plasticity
Fink, C. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00327-6 · Cited by 194 · cited 1×
“Aβ and tau also target other molecules upstream of CREB, among which the Ca2+/ calmodulin-dependent protein kinase II (CaMKII), another key molecule needed for LTP and memory formation [123].”
Microtubule structure and its stabilisation
Amos, L. A. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b403634d · Cited by 193 · cited 1×
“The N-terminal domain is rich with negative charges devoted to separation of different microtubules by electrostatic repulsion when tau is bound to a certain microtubule [46, 57, 58].”
Vasconcelos, B., Stancu, I.-C., Buist, A., Bird, M., Wang, P., Vanoosthuyse, A., Van Kolen, K., Verheyen, A., Kienlen-Campard, P., Octave, J.-N., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1525-x · Cited by 192 · cited 1×
“Also, a recent work showed that tau fibrillization can be induced in a cell-free assay by adding pre-aggregated A (cid:2) , and that A (cid:2) provide an efficient seed to induce tau cross-seeding and a consequent spreading of tau pathology in vivo [192].”
Baudier, J., & Cole, R. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60647-7 · Cited by 190 · cited 1×
“On the other hand, evidences for the interaction tau-CaMKII have been reported since the late 1980 s in works analyzing the ability of CaMKII to induce an AD-like tau phosphorylation [128, 129].”
BackgroundAxonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice
Yuan, A., Kumar, A., Peterhoff, C., Duff, K., & Nixon, R. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5242-07.2008 · Cited by 190
Delaère, P., Duyckaerts, C., Masters, C., Beyreuther, K., Piette, F., & Hauw, J.-J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90391-l · Cited by 186 · cited 1×
“Second, we know since the 1990 s that there is no correlation between A (cid:2) deposition and clinical degree of dementia among affected individuals [25–28], and plaques might occur in the brains of individuals with no sign of dementia [27, 29, 30].”
Xu, W., Weissmiller, A. M., White, J. A., Fang, F., Wang, X., Wu, Y., Pearn, M. L., Zhao, X., Sawa, M., Chen, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82409 · Cited by 182 · cited 1×
“Whether AβPP acts as a channel permeable to the oligomers [210, 211], or induces the formation of pores across the membrane to let oligomers enter the cell [212], or promotes endocytosis of the oligomers [213], is still under investigation.”
BackgroundGu, Z., Liu, W., & Yan, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806508200 · Cited by 176 · cited 1×
“-synuclein, islet amyloid polypeptide, polyglutamine, lysozyme, human insulin, and prion peptide 106–126, display a common conformation-dependent structure that is unique to soluble oligomers [193].”
Yin, Y., Gao, D., Wang, Y., Wang, Z.-H., Wang, X., Ye, J., Wu, D., Fang, L., Pi, G., Yang, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604519113 · Cited by 174 · cited 1×
“More-over, synaptic plasticity and memory impairment caused by h-tau overexpression was reported to be related to nuclear dephosphorylation/inactivation of CREB [117].”
LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
Puzzo, D., Piacentini, R., Fá, M., Gulisano, W., Li Puma, D. D., Staniszewski, A., Zhang, H., Tropea, M. R., Cocco, S., Palmeri, A., et al. (2017) · eLife · doi:10.7554/elife.26991 · Cited by 172
Self-citationTau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
Guerrero-Muñoz, M. J., Gerson, J., & Castillo-Carranza, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00464 · Cited by 168 · cited 1×
“The role of soluble oligomers also emerged in studies performed on AD mouse models, since synaptic and memory dysfunction was present before the appearance of plaques or tangles [18, 109].”
Synaptic Therapy in Alzheimer's Disease: A CREB-centric Approach
Teich, A. F., Nicholls, R. E., Puzzo, D., Fiorito, J., Purgatorio, R., Fà, M., & Arancio, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0327-5 · Cited by 166 · cited 2×
“In particular, A (cid:2) inhibits the physiological increase of CREB phosphorylation during LTP [113–115], causing a downregulation of both the NO/cGMP/PKG and the cAMP/PKA pathways, two cascades converging on CREB.”
Self-citationAmyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
Puzzo, D., & Arancio, O. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129033 · Cited by 165
Self-citationWang, Z., Jackson, R. J., Hong, W., Taylor, W. M., Corbett, G. T., Moreno, A., Liu, W., Li, S., Frosch, M. P., Slutsky, I., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2009-17.2017 · Cited by 158 · cited 1×
“We found that both oligomers of Aβ and tau require AβPP to exert their deleterious effect at the synapse [144], in agreement with previous observations indicating that A(3PP mediates extracellular Aβ neurotoxicity [143, 198, 199], and a recent study showing that AβPP is required for binding of human brain-derived olig…”
Ittner, L. M., Ke, Y. D., & Götz, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014472 · Cited by 156
Liu, C., & Götz, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084849 · Cited by 155 · cited 1×
“Moreover, the splicing process of exons 2 and 3 determines the number of 29-residue near-amino-terminal inserts which results in isoforms containing 0,1, or 2 inserts (0N, 1N, 2N) [44].”
Eidenmüller, J., Fath, T., Maas, T., Pool, M., Sontag, E., & Brandt, R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570759 · Cited by 152
The role of tau in the pathological process and clinical expression of Huntington’s disease
Vuono, R., Winder‐Rhodes, S., de Silva, R., Cisbani, G., Drouin‐Ouellet, J., REGISTRY Investigators of the European Huntington’s Disease Network, Spillantini, M. G., Cicchetti, F., & Barker, R. A. (2015) · Brain · doi:10.1093/brain/awv107 · Cited by 151 · cited 1×
“Interestingly, tau oligomers have been also found in other tauopathies such as progressive supranuclear palsy, dementia with Lewy bodies, and Huntington’s disease [101–103].”
Zhao, D., Watson, J. B., & Xie, C.-W. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00485.2004 · Cited by 151
Domert, J., Rao, S. B., Agholme, L., Brorsson, A.-C., Marcusson, J., Hallbeck, M., & Nath, S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.12.019 · Cited by 150 · cited 1×
“, oAβ1–42 TMR, oAβ3(pE)—40TMR, oAβ1—40TMR, and oAβ11–42TMR), and this prion-like spreading was attributed to an insufficient activity of cellular clearance degradation systems [171].”
A Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory
Morley, J. E., Farr, S. A., Banks, W. A., Johnson, S. N., Yamada, K. A., & Xu, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1230 · Cited by 141 · cited 1×
“Indeed, our group and others have previously demonstrated that administration of low concentration of oligomeric Aβ positively modulate synaptic function [35–37] and, conversely, blocking endogenous Aβ in the healthy brain resulted in an impairment of synaptic plasticity and memory [36, 38].”
BackgroundFogel, H., Frere, S., Segev, O., Bharill, S., Shapira, I., Gazit, N., O’Malley, T., Slomowitz, E., Berdichevsky, Y., Walsh, D. M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.024 · Cited by 138
Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments
Fraser, S. P., Suh, Y.-H., & Djamgoz, M. B. A. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10079-5 · Cited by 135
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
Van der Jeugd, A., Hochgräfe, K., Ahmed, T., Decker, J. M., Sydow, A., Hofmann, A., Wu, D., Messing, L., Balschun, D., D’Hooge, R., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0987-3 · Cited by 135 · cited 1×
“However, when the pro-aggregant tau was turned off, synaptic deficit was rescued even if insoluble tau was still present [92].”
Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice
Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L., & Brion, J.-P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070345 · Cited by 135 · cited 1×
“Soluble tau was found to be most acutely toxic in animal models of tauopathy [93, 94, 96].”
BackgroundPiacentini, R., Puma, D. D. L., Mainardi, M., Lazzarino, G., Tavazzi, B., Arancio, O., & Grassi, C. (2017) · Glia · doi:10.1002/glia.23163 · Cited by 134 · cited 2×
“On the other hand, recent studies have evidenced that the AβPP-dependent accumulation of extracellular tau oligomers in astrocytes induces a disruption of calcium signaling which in turn disrupts synaptic function in neighboring neurons [155].”
BackgroundSelf-citationShaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V., Bredesen, D. E., Koo, E. H., Shaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5032fje · Cited by 132
Tau and src family tyrosine kinases
Lee, G. S. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.002 · Cited by 131
Tampellini, D., Rahman, N., Gallo, E. F., Huang, Z., Dumont, M., Capetillo-Zarate, E., Ma, T., Zheng, R., Lu, B., Nanus, D. M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2292-09.2009 · Cited by 127 · cited 3×
“…sinceextracellularA (cid:2) induced the accumulation of intracellular A (cid:2) by stimulating A (cid:2) PP processing [143] or by a direct A (cid:2) PP-mediated internalization [144]; in turn, intracellular A (cid:2) disrupts synaptic transmission and plasticity [145].”
Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease
Yanagisawa, M., Planel, E., Ishiguro, K., & Fujita, S. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01480-5 · Cited by 123 · cited 1×
“Moreover, tau hyperphosphorylation is not a prerogative of AD, since it occurs in several other conditions such as hypothermia [87], starvation [88], chronic stress [89], and anesthesia [90, 91].”
Ripoli, C., Cocco, S., Li Puma, D. D., Piacentini, R., Mastrodonato, A., Scala, F., Puzzo, D., D'Ascenzo, M., & Grassi, C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1201-14.2014 · Cited by 122
Self-citationTau Overexpression Results in Its Secretion via Membrane Vesicles
Simón, D., García‐García, E., Gómez‐Ramos, A., Falcón‐Pérez, J. M., Díaz-Hernández, M., Hernández, F., & Ávila, J. (2012) · Neurodegenerative Diseases · doi:10.1159/000334915 · Cited by 120 · cited 1×
“However, whether the mechanism underlying tau propagation is mediated by TNTs, non-vesicular direct translocation or through secretory lysosomes into extracellular space [106, 162, 181, 182] is still under investigation.”
BackgroundAlzheimer's disease and soluble Aβ
Wısnıewskı, T., Ghiso, J. A., & Frangione, B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90105-8 · Cited by 118
The keystone of Alzheimer pathogenesis might be sought in Aβ physiology
Puzzo, D., Gulisano, W., Arancio, O., & Palmeri, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.039 · Cited by 116 · cited 2×
“Inconclusion Inconclusion,takinginto accountalmostonecenturyofresearch,itemerges thattheA (cid:2) model of AD is insufficient [40, 41] and needs to be reconsidered [34].”
Self-citationLack of correlation between plaque burden and cognition in the aged monkey
Sloane, J. A., Pietropaolo, M., Rosene, D. L., Moss, M. B., Peters, A., Kemper, T. L., & Abraham, C. R. (1997) · Acta Neuropathologica · doi:10.1007/s004010050735 · Cited by 114
Guo, J. L., & Lee, V. M. Y. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.051 · Cited by 113
Qi, H., Cantrelle, F., Benhelli‐Mokrani, H., Smet‐Nocca, C., Buée, L., Lippens, G. M., Bonnefoy, E., Galas, M., & Landrieu, I. (2015) · Biochemistry · doi:10.1021/bi5014613 · Cited by 110
Bartolotti, N., Bennett, D. A., & Lazarov, O. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.111 · Cited by 108
Whitcomb, D. J., Hogg, E. L., Regan, P., Piers, T., Narayan, P., Whitehead, G., Winters, B. L., Kim, D.-H., Kim, E., St George-Hyslop, P., et al. (2015) · Scientific Reports · doi:10.1038/srep10934 · Cited by 105 · cited 1×
“CaMKII is dysregulated in the hippocampus of AD mouse models and patients (for a review, see [124]) and it has been demonstrated that A (cid:2) oligomers interfere with its phosphorylation leading to AMPA receptor dysfunction [125–127].”
Synaptic activity and Alzheimer's disease: a critical update
Tampellini, D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00423 · Cited by 103 · cited 1×
“Thus, the high increase of extracellular Aβ during AD might be due to a derangement of this physiological loop or it could be a consequence of degeneration of neurons that have previously accumulated Aβ at intracellular level (for a review, see [142]).”
Xia, D., Li, C., & Götz, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.017 · Cited by 102 · cited 1×
“…residues, and the phosphorylation of these sites is relevant for regulating microtubule polymerization [63–66], regulation of axonal transport [67] and neurotransmitter receptors [68, 69], interference with vesicles traffick-ing [70] and apolipoprotein E [71], interaction with Src-family…”
Miyamoto, T., Stein, L., Thomas, R., Djukic, B., Taneja, P., Knox, J., Vossel, K., & Mucke, L. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0176-x · Cited by 100 · cited 1×
“The flanking region of MBD contains the majority of phosphate acceptor residues, and the phosphorylation of these sites is relevant for regulating microtubule polymerization [63–66], regulation of axonal transport [67] and neurotransmitter receptors [68, 69], interference with vesicles trafficking [70] and apolipoprot…”
BackgroundIncrease in tau tyrosine phosphorylation correlates with the formation of tau aggregates
Vega, I. E., Cui, L., Propst, J. A., Hutton, M. L., Lee, G. S., & Yen, S.-H. C. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.015 · Cited by 97 · cited 1×
“First, tau phosphorylation has been demonstrated to be responsible for aggregation only when occurring at certain residues[86],whereasinothersitesithastheopposite effectthuspreventingaggregation[80].”
Whittington, R. A., Bretteville, A., Dickler, M. F., & Planel, E. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.004 · Cited by 96 · cited 1×
“Moreover, tau hyperphosphorylation is not a prerogative of AD, since it occurs in several other conditions such as hypothermia [87], starvation [88], chronic stress [89], and anesthesia [90, 91].”
Mukhopadhyay, R., & Hoh, J. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02844-7 · Cited by 95 · cited 1×
“The N-terminal domain is rich with negative charges devoted to separation of different microtubules by electrostatic repulsion when tau is bound to a certain microtubule [46, 57, 58].”
Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau
Takahashi, M., Miyata, H., Kametani, F., Nonaka, T., Akiyama, H., Hisanaga, S.-I., & Hasegawa, M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1415-2 · Cited by 94 · cited 1×
“This binding might be related to the A (cid:2) PP-mediated uptake of A (cid:2) and tau, since A (cid:2) PP influences accumulation of tau fibrils in cultured cells [209] and is needed for the entrance of oligomeric A (cid:2) and tau into neurons [144] and astrocytes [155].”
Scala, F., Fusco, S., Ripoli, C., Piacentini, R., Li Puma, D. D., Spinelli, M., Laezza, F., Grassi, C., & D'Ascenzo, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.034 · Cited by 94
Self-citationGerson, J., Castillo-Carranza, D. L., Sengupta, U., Bodani, R., Prough, D. S., DeWitt, D. S., Hawkins, B. E., & Kayed, R. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4262 · Cited by 94 · cited 1×
“These results are in agreement with other observations reporting that tau oligomers 1) impair synaptic function and memory in wild type mice [99], 2) correlate with cognitive impairment in rTg4510 mice [100], and 3) accelerate pathology in hTau mice [101].”
Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers
Attar, A., Ripoli, C., Riccardi, E., Maiti, P., Li Puma, D. D., Liu, T., Hayes, J., Jones, M. R., Lichti-Kaiser, K., Yang, F., et al. (2012) · Brain · doi:10.1093/brain/aws289 · Cited by 93 · cited 1×
“These data led to the formulation of another theory, the “Oligomer Hypothesis” [20, 21], according to which A (cid:2) oligomers but not monomers or fibrils were responsible for synaptic dysfunction and memory loss in AD [22, 23].”
Self-citationSmith, M. A., Siedlak, S. L., Richey, P. L., Mulvihill, P., Ghiso, J. A., Frangione, B., Tagliavini, F., Giaccone, G., Bugiani, O., Praprotnik, D., et al. (1995) · Nature Medicine · doi:10.1038/nm0495-365 · Cited by 92
Singh, T. J., Wang, J., Novák, M., Kontzekova, E., Grundke, I., & Iqbal, K. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00485-1 · Cited by 91 · cited 1×
“CaMKII phosphorylates tau at different sites and this might prevent tau binding to microtubule [130] and modify tau structure leading to PHFs formation [131].”
BackgroundCriscuolo, C., Fontebasso, V., Middei, S., Stazi, M., Ammassari‐Teule, M., Yan, S. S., & Origlia, N. (2017) · Scientific Reports · doi:10.1038/srep42370 · Cited by 88 · cited 1×
“Further studies in mutant human AβPP (mhAβPP) mice have reported an age-dependent progressive deterioration of synaptic plasticity and memory spreading from the EC to the hippocampus [166], a phenomenon mediated by microglial RAGE activation and subsequent increase Gulisano et al.”
Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory
Palmeri, A., Ricciarelli, R., Gulisano, W., Rivera, D., Rebosio, C., Calcagno, E., Tropea, M. R., Conti, S., Das, U., Roy, S., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3607-16.2017 · Cited by 87 · cited 1×
“…mice and human AD patients [139, 140], this activity-dependent role of A (cid:2) should be better viewed as a physiological mechanism occurring within the healthy brain, especially because levels of A (cid:2) secreted during activity are in the pico-molar range and are not neurotoxic [35, 38, 141].”
Self-citationZheng, L., Terman, A., Hallbeck, M., Dehvari, N., Cowburn, R. F., Benedikz, E., Kågedal, K., Cedazo-Minguez, A., & Marcusson, J. (2011) · Autophagy · doi:10.4161/auto.7.12.18051 · Cited by 80 · cited 1×
“However, A (cid:2) has been shown to be secreted by neurons through exosomes [174] that could be internalized and stored from the acceptor neuron as lysosomal vesicles through a macroautophagy mediated mechanism [170, 175].”
Burnouf, S., Martire, A., Derisbourg, M., Laurent, C., Belarbi, K., Leboucher, A., Fernandez‐Gomez, F. J., Troquier, L., Eddarkaoui, S., Grosjean, M., et al. (2013) · Aging Cell · doi:10.1111/acel.12018 · Cited by 79 · cited 1×
“Recently, a loss of BDNF has been also reported in THY-Tau22 and P301L mouse models of tau pathology [134, 135].”
Tau oligomers in cerebrospinal fluid in Alzheimer's disease
Sengupta, U., Portelius, E., Hansson, O., Farmer, K., Castillo‐Carranza, D., Woltjer, R., Zetterberg, H., Galasko, D., Blennow, K., & Kayed, R. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.382 · Cited by 77 · cited 1×
“First, the possibility to evaluate the presence of extracellular oligomeric tau in clinical lumbar CSF specimens could be useful as a possible early biomarker of the disease, in agreement with other findings [102, 106].”
Result
Cited by
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz099 · Cited by 1,547
“Research into Alzheimer’s disease has provided additional topical caveats (Gulisano et al., 2018; Hunter et al., 2018; Morris et al., 2018).”
BackgroundZhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Alzheimer’s disease: Recent treatment strategies
Vaz, M., & Silvestre, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173554 · Cited by 547
Gadhave, D. G., Sugandhi, V. V., Jha, S. K., Nangare, S. N., Gupta, G., Singh, S. K., Dua, K., Cho, H., Hansbro, P. M., & Paudel, K. R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102357 · Cited by 358
“3 B) (Gulisano et al., 2018).”
Zhang, W., Xu, C., Sun, J., Shen, H.-M., Wang, J., & Yang, C. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.008 · Cited by 205
Metadata
- Authors
- Gulisano, W., Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D’Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., Puzzo, D., & Arancio, O.
- Affiliations
- University of Catania (IT)
- Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University, New York, NY, USA
- Columbia University (US)
- Università Cattolica del Sacro Cuore (IT)
- Department of Pharmacology, Physiology and Neuroscience, Rutgers University, Newark, NJ, USA
- Corresponding author
- Puzzo, Daniela
- Arancio, Ottavio
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2018-06-12
- Volume
- 64
- Issue
- s1
- Pages
- S611-S631
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC8371153
- OpenAlex
- W2807540667
- Cited by
- 313
- References
- 223
- Citations by year
- 2026: 59 · 2025: 92 · 2024: 60 · 2023: 32 · 2022: 23 · 2021: 17 · 2020: 18 · 2019: 10 · 2018: 2
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, public-domain)
- Funders
- National Institute on Aging (R01AG049402, R01AG017761)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta
- MeSH terms
- Alzheimer Disease, Animals, Humans, Signal Transduction, Amyloid beta-Peptides, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.